Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 227 across all filing types
Latest filing 2022-11-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company Bioplus. It provides specific details such as the reference price and the effective date. This falls under the category of capital changes or share issues, specifically fitting the 'Share Issue/Capital Change' category.
2022-11-22 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Bio Plus Co., Ltd. covering the period from January 1, 2022, to September 30, 2022. It contains detailed corporate information, business descriptions, capital changes, and financial disclosures typical of a formal quarterly filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange. It is not an announcement of a report, but the report itself. 9M 2022
2022-11-14 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding a temporary suspension of stock trading due to a bonus issue (무상증자). It is a specific regulatory announcement issued by the exchange, not a full report or financial statement. Since it does not fit into specific categories like share issuance or dividend announcements, it falls under the general regulatory filing category.
2022-11-09 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a 'Decision on Bonus Issue' (무상증자결정). This document details the issuance of new shares to existing shareholders, which constitutes a change in the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2022-11-09 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of a bonus issue (free share distribution). It does not contain full financial statements or proxy materials, but rather serves as a formal notice of a corporate action. Since it does not fit into specific categories like dividend announcements or share buybacks, and is a standard regulatory disclosure, it is classified as a general regulatory filing.
2022-11-09 Korean
증권발행결과(자율공시)(제3자배정 유상증자-상환전환우선주)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Bioplus regarding the results of a third-party capital increase (issuance of redeemable convertible preferred shares). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2022-10-24 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.